Integrity Laboratories Covers New COVID-19 Variants
Integrity Laboratories Covers New COVID-19 Variants
According to the World Health Organization (WHO) new variants of SARS-CoV-2 virus are highly contagious and have now spread to over 80 countries. As they continue to mutate, the early detection of infected individuals with SARS-CoV-2 virus within our communities is critical to prevent the transmission of COVID-19 disease.
Our COVID-19 test by Integrity Laboratories successfully detects original as well multiple new mutant variants of SARS-CoV-2 virus, including Delta variant and 2 additional mutants originated from India, Mu and Lamda.
In our results reports of our COVID-19 test, we provide Viral Load IndicatorTM (VLITM) values, in addition to results for detection of SARS-CoV-2 virus. VLITM achieved by AmpliteCtTM is a quantitative method that can broadly categorize the concentration of SARS-CoV-2 virus genetic material in patients using RT-PCR technology.
The current list of CDC recognized variants can be properly detected through our intercept PCR(™) platform.
- Alpha (B.1.1.7 and Q lineages)
- Beta (B.1.351 and descendent lineages)
- Gamma (P.1 and descendent lineages)
- Epsilon (B.1.427 and B.1.429)
- Eta (B.1.525)
- Iota (B.1.526)
- Kappa (B.1.617.1)
- 1.617.3
- Mu (B.1.621, B.1.621.1)
- Zeta (P.2)
- Delta (B.1.617.2 and AY lineages)
- Omicron
- To date, no variants of high consequence have been identified in the United States.
SARS-CoV-2 Delta Variant Detected by Integrity Laboratories FDA EUA approved Assay
9 Viral Variants | 3 Viral Load Indicators | 1 RT-PCR Test
| NIH GenBank® ID | GISAID Name |
|---|---|
| MT007544.1 | Australia/VIC01/2020 |
| MN908947.3 | Wuhan-Hu-1 |
| LC528232.1 | Japan/Hu_DP_Kng_19-020/2020 |
| MT106054.1 | USA/TX1/2020 |
| MT188340 | USA/MN2-MDH2/2020 |
| MT118835 | USA/CA9/2020 |
| EPI_ISL_710528 | England/205041766/2020 |
| EPI_ISL_601443 | England/MILK-9E05B3/2020 |
